Medicinal cannabis company, MGC Pharma
(ASX:MXC) has announced that luxury UK retailer Harvey Nichols will stock its MGC Derma and Derma Plus Cosmetics lines.
The premium range of 18 products containing cannabidiol will be sold via the retailers Beyond Beauty Department and on their e-commerce platform from the 29th of June.
The company says the products are research backed and independently tested, with 92 per cent of participants saying they would use the products on a daily basis.
MGC Pharmaceuticals says the deal demonstrates a ramp up of commercialisation and material brand penetration.
Shares in Mgc Pharma
(ASX:MXC) are trading 4.76 per cent higher to 7 cents.
